Alkem Labs Gets Appellate Relief in Rs 660.77 Crore Income Tax Dispute
Written By : Parthika Patel
Published On 2026-07-04 17:38 GMT | Update On 2026-07-04 17:38 GMT
Advertisement
New Delhi: Alkem Laboratories Limited has informed the stock exchanges that it has received favourable Orders-in-Appeal from the Commissioner of Income Tax (Appeals) - 47, Mumbai [CIT(A)], which deleted tax disallowances made under Section 80-IE of the Income-tax Act, 1961 involving a tax amount of Rs 660.77 crore.
The company disclosed the development under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, stating that the details of the orders have been provided in accordance with Clause 20 of Para A of Part A of Schedule III of the SEBI Listing Regulations.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.